ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Medical Oncology

Top Medical Oncology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALEX EHSAN M.D,

Medical Oncology

3,709

$652K

379
278 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$176
Average prescription price

Avg: $412

JESUS GOMEZ M.D.

Medical Oncology

3,286

$695K

345
297 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$211
Average prescription price

Avg: $412

LARRY BARKER M.D.

Medical Oncology

2,598

$528K

242
200 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$203
Average prescription price

Avg: $412

JAY SCHACHNER MD

Medical Oncology

2,410

$1.28M

241
191 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

34%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$532
Average prescription price

Avg: $412

PASQUALE DELIZIO M.D.

Medical Oncology

2,404

$415K

225
169 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 19%

$173
Average prescription price

Avg: $412

ROBERT BERRYMAN M.D.

Medical Oncology

2,314

$982K

155
109 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 19%

$425
Average prescription price

Avg: $412

CHARLES DEUR M.D.

Medical Oncology

2,245

$1.05M

246
223 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 16%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$468
Average prescription price

Avg: $412

MOHAMMED QURAISHI M.D.

Medical Oncology

2,210

$466K

259
228 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 19%

$211
Average prescription price

Avg: $412

LARRY FRASE M.D.

Medical Oncology

2,145

$602K

179
146 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$281
Average prescription price

Avg: $412

MARK REDROW MD

Medical Oncology

1,752

$447K

264
230 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$255
Average prescription price

Avg: $412

SUSAN TAYLOR M.D.

Medical Oncology

1,692

$625K

215
191 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 19%

$369
Average prescription price

Avg: $412

GREGORY SEYMOUR MD

Medical Oncology

1,631

$540K

201
162 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$331
Average prescription price

Avg: $412

ROBERT BIRDWELL M.D.

Medical Oncology

1,592

$359K

150
132 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$226
Average prescription price

Avg: $412

SAMER BIBAWI MD

Medical Oncology

1,587

$1.03M

194
165 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 19%

$650
Average prescription price

Avg: $412

SANJAY OOMMEN MD

Medical Oncology

1,543

$691K

202
163 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$448
Average prescription price

Avg: $412

IBRAHIM SHALABY MD

Medical Oncology

1,534

$614K

234
201 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 19%

$400
Average prescription price

Avg: $412

ERNEST COCHRAN M.D.

Medical Oncology

1,532

$411K

196
149 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 19%

$268
Average prescription price

Avg: $412

JOHN PATLAN M.D.

Medical Oncology

1,527

$131K

132
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 19%

$85
Average prescription price

Avg: $412

BRIAN PRUITT M.D.

Medical Oncology

1,501

$206K

261
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 19%

$137
Average prescription price

Avg: $412

JEONG OH M.D.

Medical Oncology

1,465

$94.9K

179
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 19%

$65
Average prescription price

Avg: $412

DENNIS COSTA M.D.

Medical Oncology

1,405

$711K

132
105 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$506
Average prescription price

Avg: $412

ANITA THARIAN DO

Medical Oncology

1,394

$529K

162
137 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 19%

$380
Average prescription price

Avg: $412

MARYADA REDDY M. D.

Medical Oncology

1,384

$1.08M

232
189 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 16%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 19%

$784
Average prescription price

Avg: $412

DOUGLAS NELSON M.D.

Medical Oncology

1,320

$357K

151
123 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 19%

$270
Average prescription price

Avg: $412

ROBERT AMATO D.O.

Medical Oncology

1,301

$889K

132
106 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$684
Average prescription price

Avg: $412

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank